Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Though alternative methods are emerging (more on that below), solid-phase synthesis remains the most common approach today
Employers only pay when predefined outcomes are achieved Guaranteed improvements in A1C, weight loss, and deprescription of GLP-1s and other medications ROI is validated using pharmacy and medical claims data Reported outcomes include a 2.2-point average A1C reduction for members with starting A1C greater than8.0 and a 14-pound average weight loss for members with a BMI greater than 30, based on internal data from Twin Healths commercial populations as of September 2024 Demonstrated reductions in diabetes-related pharmacy spend while maintaining clinical appropriateness Precision medication management Employers can start by using claims and clinical data to identify risk levels and guide GLP-1 eligibility
G.BermanR
Thyroid labs (TSH, Free T4, Free T3) should be checked every 68 weeks when starting or adjusting GLP-1 or thyroid medications
Cellular protection
US$ 20.42
US$ 23.66
US$ 20.27
US$ 24.47
